Anacetrapib, a cholesteryl ester transfer protein inhibitor

AJ Hooper, JR Burnett - Expert Opinion on Investigational Drugs, 2012 - Taylor & Francis
Introduction: Inhibition of cholesteryl ester transfer protein (CETP) has the ability to increase
high-density lipoprotein (HDL)-cholesterol levels and potentially reduce cardiovascular risk …
被引用次数：13 相关文章

Anacetrapib, a cholesteryl ester transfer protein inhibitor.

AJ Hooper, JR Burnett - Expert Opinion on Investigational Drugs, 2011 - europepmc.org
Inhibition of cholesteryl ester transfer protein (CETP) has the ability to increase high-density
lipoprotein (HDL)-cholesterol levels and potentially reduce cardiovascular risk. The first …

Anacetrapib, a cholesteryl ester transfer protein inhibitor

AJ Hooper, JR Burnett - Expert opinion on investigational …, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction Inhibition of cholesteryl ester transfer protein (CETP) has the ability to increase
high-density lipoprotein (HDL)-cholesterol levels and potentially reduce cardiovascular risk …

[引用][C] Anacetrapib, a cholesteryl ester transfer protein inhibitor

A Hooper, J Burnett - Expert Opinion on …, 2012 - research-repository.uwa.edu.au
Anacetrapib, a cholesteryl ester transfer protein inhibitor — the UWA Profiles and Research
Repository Skip to main navigation Skip to search Skip to main content the UWA Profiles and …